Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes

NCT00571935 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin aspart
DRUG: soluble human insulin

Sponsor

Novo Nordisk A/S